Aarhus University Seal

Publications

Sort by: Date | Author | Title

Stewart, C. B., Sathyanarayana, S., Foster, V. K., Iredale, R., Galley, D., Pasquini, J., Anderson, K. N., Pavese, N. & Ledingham, D. (2026). Combined Effects of Depression, Fatigue and Cardiovascular Dysfunction on Functional Dependence Over Seven Years in Early Parkinson's Disease. Movement Disorders Clinical Practice, 13(2), 399-409. https://doi.org/10.1002/mdc3.70291
Cilia, R., Arnaldi, D., Ballanger, B., Ceravolo, R., De Micco, R., Del Sole, A., Eleopra, R., Endo, H., Fasano, A., Hoenig, M. C., Horsager, J., Lehéricy, S., Leta, V., Moda, F., Nolano, M., Outeiro, T. F., Parkkinen, L., Pavese, N., Quattrone, A. ... van Eimeren, T. (2026). Neuroimaging and Pathology Biomarkers in Parkinson’s Disease and Parkinsonism. Brain sciences, 16(1), Article 110. https://doi.org/10.3390/brainsci16010110
Sathyanarayana, S., Pasquini, J., Ledingham, D., Mitra, D., Warren, N. & Pavese, N. (2025). Case report -Cavernoma involving substantia nigra and nigrostriatal pathway as a rare cause of secondary parkinsonism with a 5 year follow up. Parkinsonism and Related Disorders, 132, Article 107281. https://doi.org/10.1016/j.parkreldis.2025.107281
Pasquini, J., Pavese, N., Ceravolo, R., Helmich, R. C. & Deuschl, G. (2025). Contralateral Spread of Asymmetrical Tremor in Parkinson's Disease. Movement Disorders Clinical Practice. Advance online publication. https://doi.org/10.1002/mdc3.70353
Sun, L., Landau, A. M., Tang, J. & Roivainen, A. (2025). Dark seasons enhance brain and brown adipose tissue interactions related to mu-opioid receptor signaling. European journal of nuclear medicine and molecular imaging, 52(10), 3534-3539. https://doi.org/10.1007/s00259-025-07272-5
Ledingham, D., Gibbs, M., Mills, R., Jenkins, A., Nicholson, C., Hussain, M. A., Baker, M. & Pavese, N. (2025). Decoding Cervical Dystonia: Insights from Local Field Potentials in a Case Study Utilizing Open-Source Toolboxes. Movement Disorders Clinical Practice, 12(10), 1675-1678. https://doi.org/10.1002/mdc3.70164
Palermo, G., Aghakhanyan, G., Bellini, G., Giannoni, S., Vadi, G., Francischello, R., Nonne, G., Tedeschi, M. G., Morganti, R., Frosini, D., Pavese, N., Volterrani, D. & Ceravolo, R. (2025). Discriminating between proposed Brain-First and Body-First Parkinson’s disease using conventional and radiomics-enhanced dopamine transporter SPECT image analysis. npj Parkinson's Disease , 11(1), Article 328. https://doi.org/10.1038/s41531-025-01164-z
Palermo, G., Giannoni, S., Tommasini, L., Bellini, G., Frosini, D., Aghakhanyan, G., Morganti, R., Volterrani, D., Pavese, N. & Ceravolo, R. (2025). Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson’s Disease. Aging and Disease, 16(3), 1754-1768. https://doi.org/10.14336/AD.2024.0553
Edison, P., Femminella, G. D., Ritchie, C., Nowell, J., Holmes, C., Walker, Z., Ridha, B., Raza, S., Livingston, N. R., Frangou, E., Love, S., Williams, G., Lawrence, R., Mcfarlane, B., Archer, H., Coulthard, E., Underwood, B. R., Koranteng, P., Karim, S. ... Ballard, C. (2025). Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial. Nature Medicine. Advance online publication. https://doi.org/10.1038/s41591-025-04106-7
Pasquini, J., Sigurdsson, H. P., Firbank, M., Best, L., Foster, V., Galley, D., Maxwell, R., Silani, V., Ceravolo, R., Petrides, G., Brooks, D. J. & Pavese, N. (2025). Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy. Journal of Neurology, 272(3), 195. Article 195. https://doi.org/10.1007/s00415-025-12932-5
Galgani, A., Lombardo, F., Frijia, F., Scotto, M., Tognoni, G., Pavese, N. & Giorgi, F. S. (2025). Locus Coeruleus Sexual Dimorphism and Its Impact on Cognitive Impairment and Cortical Atrophy in Alzheimer's Disease. Neurodegenerative Diseases, 25(2), 53-66. https://doi.org/10.1159/000544882
Paranathala, M. P., Mills, R., Rai, P., Pavese, N., Hussain, M. A., Duddy, M., Nicholson, C. & Jenkins, A. (2025). Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor. British Journal of Neurosurgery, 39(4), 465-470. https://doi.org/10.1080/02688697.2023.2277284
Anzalone, M., Karam, S. A., Briting, S. R. R., Petersen, S., Thomsen, M. B., Babcock, A. A., Landau, A. M., Finsen, B. & Metaxas, A. (2025). Serotonin-2B receptor (5-HT2BR) expression and binding in the brain of APPswe/PS1dE9 transgenic mice and in Alzheimer's disease brain tissue. Neuroscience Letters, 844, Article 138013. https://doi.org/10.1016/j.neulet.2024.138013
Pasquini, J., Firbank, M. J., Best, L., Foster, V., Stewart, C., Silani, V., Durcan, R., Roberts, G., Petrides, G., Ceravolo, R., Brooks, D. J., Anderson, K. N. & Pavese, N. (2025). Substantia nigra and locus coeruleus microstructural abnormalities in isolated rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain Communications, 7(1), fcaf023. Article fcaf023. https://doi.org/10.1093/braincomms/fcaf023
Baun, A. M., Firbank, M., Hinz, R., Terkelsen, M. H., Iranzo, A., Gaig, C., Tolosa, E., Brooks, D. J., Pavese, N. & Keogh, M. (2025). [11C](R)-PK11195 Positron Emission Tomography Imaging of Skull Inflammation in Isolated Rapid-Eye-Movement Sleep Behavior Disorder. Movement disorders : official journal of the Movement Disorder Society. Advance online publication. https://doi.org/10.1002/mds.70133
Sathyanarayana, S., Pavese, N. & Ledingham, D. (2025). The cholinergic system in dementia with Lewy bodies. In C. Cuello (Ed.), Cholinergic Involvement in Neurodegenerative Diseases (pp. 231-245). Elsevier. https://doi.org/10.1016/B978-0-443-19088-9.00008-1
Pasquini, J., Brooks, D. J. & Pavese, N. (2025). The involvement of the cholinergic system in Parkinson disease. In C. Cuello (Ed.), Cholinergic Involvement in Neurodegenerative Diseases (pp. 215-229). Elsevier. https://doi.org/10.1016/B978-0-443-19088-9.00001-9
Ledingham, D., Sathyanarayana, S., Stewart, C. B., Iredale, R., Foster, V., Galley, D., Baker, M. & Pavese, N. (2025). Tracking Motor Progression and Device-Aided Therapy Eligibility in Parkinson's Disease. Annals of Clinical and Translational Neurology. Advance online publication. https://doi.org/10.1002/acn3.70188
Hvingelby, V., Carra, R. B., Terkelsen, M. H., Hamani, C., Capato, T., Košutzká, Z., Krauss, J. K., Moro, E., Pavese, N., Cury, R. G. & Gait Study Group (2024). A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies. Movement Disorders Clinical Practice, 11(8), 927-947. https://doi.org/10.1002/mdc3.14143
Tuil, M. E., Calsolaro, V., Crook, H., Femminella, G. D., Pasqualetti, G., Buckley, C., Trigg, W., Gentleman, S., Brooks, D. J., Jogaudaite, S., Abarrategui, J. A., Hinz, R. & Edison, P. (2024). Basic Science and Pathogenesis. Alzheimer's & dementia : the journal of the Alzheimer's Association, 20 Suppl 1, e092255. Article e092255. https://doi.org/10.1002/alz.092255
Firbank, M. J., Pasquini, J., Best, L., Foster, V., Sigurdsson, H. P., Anderson, K. N., Petrides, G., Brooks, D. J. & Pavese, N. (2024). Cerebellum and basal ganglia connectivity in isolated REM sleep behaviour disorder and Parkinson's disease: an exploratory study. Brain Imaging and Behavior, 18(6), 1428-1437. https://doi.org/10.1007/s11682-024-00939-x
Leng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J. & Edison, P. (2024). Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects. Journal of Alzheimer's Disease, 100(3), 973-986. https://doi.org/10.3233/JAD-230442
Sigurdsson, H. P., Alcock, L., Firbank, M., Wilson, R., Brown, P., Maxwell, R., Bennett, E., Pavese, N., Brooks, D. J. & Rochester, L. (2024). Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait. NeuroImage, 288, Article 120531. https://doi.org/10.1016/j.neuroimage.2024.120531
Pasquini, J., Firbank, M. J., Best, L., Foster, V., Galley, D., Silani, V., Ceravolo, R., Petrides, G., Brooks, D. J., Anderson, K. N. & Pavese, N. (2024). Hypothalamic involvement in multiple system atrophy: A structural MRI study. Journal of the Neurological Sciences, 460, Article 122985. https://doi.org/10.1016/j.jns.2024.122985
Theis, H., Pavese, N., Rektorová, I. & Van Eimeren, T. (2024). Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease. Journal of Parkinson's Disease, 14(s2), S353-S365. https://doi.org/10.3233/JPD-230385
Ellis, E. G., Meyer, G. M., Kaasinen, V., Corp, D. T., Pavese, N., Reich, M. M. & Joutsa, J. (2024). Multimodal neuroimaging to characterize symptom-specific networks in movement disorders. npj Parkinson's Disease , 10(1), Article 154. https://doi.org/10.1038/s41531-024-00774-3
Sauerbier, A., Herberg, J., Stopic, V., Loehrer, P. A., Ashkan, K., Rizos, A., Jost, S. T., Schneider, C., Visser-Vandewalle, V., Evans, J., Nimsky, C., Fink, G. R., Antonini, A., Martinez-Martin, P., Silverdale, M., Weintraub, D., Schrag, A., Ray Chaudhuri, K., Timmermann, L. ... EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2024). Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease. npj Parkinson's Disease , 10(1), Article 114. https://doi.org/10.1038/s41531-024-00701-6
Galgani, A., Lombardo, F., Frijia, F., Martini, N., Tognoni, G., Pavese, N. & Giorgi, F. S. (2024). The degeneration of locus coeruleus occurring during Alzheimer’s disease clinical progression: a neuroimaging follow-up investigation. Brain Structure & Function, 229(5), 1317-1325. https://doi.org/10.1007/s00429-024-02797-1
Cai, X. L., Pu, C. C., Zhou, S. Z., Wang, Y., Huang, J., Lui, S. S. Y., Moller, A., Cheung, E. F. C., Madsen, K. H., Xue, R., Yu, X. & Chan, R. C. K. (2023). Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal 1H-MRS and fMRI study. Psychological Medicine, 53(11), 4904-4914. https://doi.org/10.1017/S0033291722001817
Aghakhanyan, G., Galgani, A., Vergallo, A., Lombardo, F., Martini, N., Baldacci, F., Tognoni, G., Leo, A., Guidoccio, F., Siciliano, G., Fornai, F., Pavese, N., Volterrani, D. & Giorgi, F. S. (2023). Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study. Neurobiology of Aging, 122, 12-21. https://doi.org/10.1016/j.neurobiolaging.2022.11.002
Okkels, N., Horsager, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2023). Cholinergic Imaging and Dementia. In Molecular Imaging of Neurodegenerative Disorders (pp. 127-144). Springer International Publishing. https://doi.org/10.1007/978-3-031-35098-6_8
Galgani, A., Palermo, G., Lombardo, F., Martini, N., Bastiani, L., Vergallo, A., Tommasini, L., Bellini, G., Baldacci, F., Frosini, D., Tognoni, G., Gesi, M., Cademartiri, F., Fornai, F., Pavese, N., Ceravolo, R. & Giorgi, F. S. (2023). Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies. Current Alzheimer research, 20(4), 277-288. https://doi.org/10.2174/1567205020666230721144603
Galgani, A., Lombardo, F., Martini, N., Vergallo, A., Bastiani, L., Hampel, H., Hlavata, H., Baldacci, F., Tognoni, G., De Marchi, D., Ghicopulos, I., De Cori, S., Biagioni, F., Busceti, C. L., Ceravolo, R., Bonuccelli, U., Chiappino, D., Siciliano, G., Fornai, F. ... Giorgi, F. S. (2023). Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia. European Journal of Neurology, 30(1), 32-46. https://doi.org/10.1111/ene.15556
Leng, F., Hinz, R., Gentleman, S., Hampshire, A., Dani, M., Brooks, D. J. & Edison, P. (2023). Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease. Molecular Psychiatry, 28(3), 1303-1311. https://doi.org/10.1038/s41380-022-01878-z
Kirkeby, A., Nelander, J., Hoban, D. B., Rogelius, N., Bjartmarz, H., Novo Nordisk Cell Therapy R&D, Storm, P., Fiorenzano, A., Adler, A. F., Vale, S., Mudannayake, J., Zhang, Y., Cardoso, T., Mattsson, B., Landau, A. M., Glud, A. N., Sørensen, J. C., Lillethorup, T. P., Lowdell, M. ... Parmar, M. (2023). Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. Cell Stem Cell, 30(10), 1299-1314.e9. https://doi.org/10.1016/j.stem.2023.08.014
Street, D., Jabbari, E., Costantini, A., Jones, P. S., Holland, N., Rittman, T., Jensen, M. T., Chelban, V., Goh, Y. Y., Guo, T., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Revesz, T., Warner, T. T., Lees, A. J. ... Rowe, J. B. (2023). Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials. Brain, 146(8), 3232-3242. https://doi.org/10.1093/brain/awad105
Pasquini, J., Deuschl, G., Pecori, A., Salvadori, S., Ceravolo, R. & Pavese, N. (2023). The Clinical Profile of Tremor in Parkinson's Disease. Movement Disorders Clinical Practice, 10(10), 1496-1506. https://doi.org/10.1002/mdc3.13845
Stewart, C. B., Ledingham, D., Foster, V. K., Anderson, K. N., Sathyanarayana, S., Galley, D., Pavese, N. & Pasquini, J. (2023). The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study. Frontiers in Neurology, 14, Article 1155669. https://doi.org/10.3389/fneur.2023.1155669
Ray Chaudhuri, K., Leta, V., Bannister, K., Brooks, D. J. & Svenningsson, P. (2023). The noradrenergic subtype of Parkinson disease: from animal models to clinical practice. Nature Reviews Neurology, 19(6), 333-345. https://doi.org/10.1038/s41582-023-00802-5
Galgani, A., Vergallo, A., Campese, N., Lombardo, F., Pavese, N., Petrozzi, L., LoGerfo, A., Franzini, M., Cecchetti, D., Puglisi-Allegra, S., Busceti, C. L., Siciliano, G., Tognoni, G., Baldacci, F., Lista, S., Hampel, H., Fornai, F. & Giorgi, F. S. (2022). Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum. Journal of Neurochemistry, 163(1), 40-52. https://doi.org/10.1111/jnc.15686
Sigurdsson, H. P., Yarnall, A. J., Galna, B., Lord, S., Alcock, L., Lawson, R. A., Colloby, S. J., Firbank, M. J., Taylor, J.-P., Pavese, N., Brooks, D. J., O'Brien, J. T., Burn, D. J. & Rochester, L. (2022). Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease. Movement Disorders, 37(6), 1222-1234. https://doi.org/10.1002/mds.28977
Cury, R. G., Pavese, N., Aziz, T. Z., Krauss, J. K., Moro, E. & the Neuromodulation of Gait Study Group from Movement Disorders Society (2022). Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease. npj Parkinson's Disease , 8(1), Article 8. https://doi.org/10.1038/s41531-021-00276-6
Giorgi, F. S., Martini, N., Lombardo, F., Galgani, A., Bastiani, L., Della Latta, D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi-Allegra, S., Pavese, N. & Fornai, F. (2022). Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach. Journal of Neural Transmission, 129(4), 387-394. https://doi.org/10.1007/s00702-022-02486-5
Giorgi, F. S., Lombardo, F., Galgani, A., Hlavata, H., Della Latta, D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., Scalese, M., Bastiani, L., Keilberg, P., De Marchi, D., Fornai, F. & Bonuccelli, U. (2022). Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects. Brain Imaging and Behavior, 16(3), 1077-1087. https://doi.org/10.1007/s11682-021-00562-0
Xu, Z., Anderson, K. N. & Pavese, N. (2022). Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 22(10), 635-655. https://doi.org/10.1007/s11910-022-01223-5
Brooks, D. J. (2022). Neuroimaging Studies in Non-Motor Parkinson's Disease Symptoms. In Non-Motor Parkinson's Disease (pp. 46-61). Cambridge University Press. https://doi.org/10.1017/9781009039291.006
Xing, Y., Sapuan, A. H., Martín-Bastida, A., Naidu, S., Tench, C., Evans, J., Sare, G., Schwarz, S. T., Al-bachari, S., Parkes, L. M., Kanavou, S., Raw, J., Silverdale, M., Bajaj, N., Pavese, N., Burn, D., Piccini, P., Grosset, D. G. & Auer, D. P. (2022). Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. Movement Disorders, 37(5), 1028-1039. https://doi.org/10.1002/mds.28934
Pineda-Pardo, J. D. S. A., Sánchez-Ferro, Á., Monje, M. H. G., Pavese, N. & Obeso, J. A. (2022). Onset pattern of nigrostriatal denervation in early Parkinson's disease. Brain, 145(3), 1018-1028. https://doi.org/10.1093/brain/awab378
Schofield, C., Chaudhuri, K. R., Carroll, C., Sharma, J. C., Pavese, N., Evans, J., Foltynie, T., Reichmann, H., Zurowska, L., Soares-Da-Silva, P. & Lees, A. (2022). Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. Neurodegenerative Disease Management, 12(2), 77-91. https://doi.org/10.2217/nmt-2021-0057
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J. & Amyloid Biomarker Study Group (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology, 79(3), 228-243. https://doi.org/10.1001/jamaneurol.2021.5216
Jiang, R., Chazot, P., Pavese, N., Crookes, D., Bouridane, A. & Celebi, M. E. (2022). Private Facial Prediagnosis as an Edge Service for Parkinson's DBS Treatment Valuation. IEEE Journal of Biomedical and Health Informatics, 26(6), 2703-2713. https://doi.org/10.1109/JBHI.2022.3146369
O’Brien, J. T., Chouliaras, L., Sultana, J., Taylor, J. P., Ballard, C. & on behalf of the RENEWAL Study Group (2022). RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alzheimer's Research & Therapy, 14(1), Article 169. https://doi.org/10.1186/s13195-022-01103-7
Zhang, Z., Jiang, R., Zhang, C., Williams, B., Jiang, Z., Li, C. T., Chazot, P., Pavese, N., Bouridane, A. & Beghdadi, A. (2022). Robust Brain Age Estimation Based on sMRI via Nonlinear Age-Adaptive Ensemble Learning. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 30, 2146-2156. https://doi.org/10.1109/TNSRE.2022.3190467
Jesuthasan, A., Garcia, L. R. & Pavese, N. (2022). Studying cognitive function in patients with a long-standing diagnosis of SWEDD. Journal of the Neurological Sciences, 441, Article 120353. https://doi.org/10.1016/j.jns.2022.120353
Lang, A. E., Siderowf, A. D., Macklin, E. A., Poewe, W., Brooks, D. J., Fernandez, H. H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C. M., Postuma, R. B., Simon, D. K., Tolosa, E., Mollenhauer, B., Cedarbaum, J. M., Fraser, K., Xiao, J., Evans, K. C., Graham, D. L. ... SPARK Investigators (2022). Trial of Cinpanemab in Early Parkinson's Disease. The New England Journal of Medicine, 387(5), 408-420. https://doi.org/10.1056/NEJMoa2203395
Devos, D., Labreuche, J., Rascol, O., Corvol, J. C., Duhamel, A., Delannoy, P. G., Poewe, W., Compta, Y., Pavese, N., Ruzička, E., Dušek, P., Post, B., Bloem, B. R., Berg, D., Maetzler, W., Otto, M., Habert, M. O., Lehericy, S., Ferreira, J. ... FAIRPARK-II Study Group (2022). Trial of Deferiprone in Parkinson's Disease. New England Journal of Medicine, 387(22), 2045-2055. https://doi.org/10.1056/NEJMoa2209254
the PASADENA Investigators and Prasinezumab Study Group (2022). Trial of Prasinezumab in Early-Stage Parkinson's Disease. New England Journal of Medicine, 387(5), 421-432. https://doi.org/10.1056/NEJMoa2202867
Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D. J., Martarello, L., Comley, R. A., Chen, L., Schwarz, A. J., Hargreaves, R., Gunn, R. N., Rabiner, E. A. & Matthews, P. M. (2022). Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease. Science Translational Medicine, 14(658), Article eabk1051. https://doi.org/10.1126/scitranslmed.abk1051
Lang, A., Siderowf, A., Macklin, E., Poewe, W., Brooks, D., Fernandez, H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C., Postuma, R., Simon, D., Tolosa, E., Mollenhauer, B., Byrne, M., Fraser, K., Xiao, J., Sapir, I., Inra, J. ... Fox, T. (2021). Cinpanemab in Early Parkinson's Disease: Phase 2 SPARK Study Results. Movement Disorders, 36(S1), S180-S181. Article 408. https://doi.org/10.1002/mds.28794
Femminella, G. D., Livingston, N. R., Raza, S., van der Doef, T., Frangou, E., Love, S., Busza, G., Calsolaro, V., Carver, S., Holmes, C., Ritchie, C. W., Lawrence, R. M., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E. ... Edison, P. (2021). Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy, 13(1), Article 47. https://doi.org/10.1186/s13195-021-00784-w
Cristiano Real Gregório, C., Henrique Binda, K. & Landau, A. (2021). Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and Diet: Treadmill exercise and neuroinflammation: Links with aging. In Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and Diet: Treadmill exercise and neuroinflammation: Links with aging (pp. 385-401). Academic Press.
Leng, F., Hinz, R., Gentleman, S., Brooks, D. J. & Edison, P. (2021). Neuroinflammation, functional connectivity and structural network integrity in the Alzheimer's spectrum. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(S3), e055970. https://doi.org/10.1002/alz.055970
Cai, X. L., Wang, Y. M., Wang, Y., Zhou, H. Y., Huang, J., Wang, Y., Lui, S. S. Y., Møller, A., Hung, K. S. Y., Mak, H. K. F., Sham, P. C., Cheung, E. F. C. & Chan, R. C. K. (2021). Neurological Soft Signs Are Associated with Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia. Schizophrenia Bulletin, 47(5), 1452-1462. https://doi.org/10.1093/schbul/sbaa200
Jost, S. T., Visser-Vandewalle, V., Rizos, A., Loehrer, P. A., Silverdale, M., Evans, J., Samuel, M., Petry-Schmelzer, J. N., Sauerbier, A., Gronostay, A., Barbe, M. T., Fink, G. R., Ashkan, K., Antonini, A., Martinez-Martin, P., Chaudhuri, K. R., Timmermann, L., Dafsari, H. S. & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2021). Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. Parkinson's Disease, 7(1), Article 48. https://doi.org/10.1038/s41531-021-00174-x
Xu, Z., Anderson, K. N., Saffari, S. E., Lawson, R. A., Chaudhuri, K. R., Brooks, D. & Pavese, N. (2021). Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study. Journal of Neurology, 268(1), 312-320. https://doi.org/10.1007/s00415-020-10140-x
Kuebler, L., Buss, S., Leonov, A., Ryazanov, S., Schmidt, F., Maurer, A., Weckbecker, D., Landau, A. M., Lillethorup, T. P., Bleher, D., Saw, R. S., Pichler, B. J., Griesinger, C., Giese, A. & Herfert, K. (2021). [11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1759–1772 . https://doi.org/10.1007/s00259-020-05133-x
Pasquini, J., Brooks, D. J. & Pavese, N. (2021). The Cholinergic Brain in Parkinson's Disease. Movement Disorders Clinical Practice, 8(7), 1012-1026. https://doi.org/10.1002/mdc3.13319
Nicholas, R., Brooks, D. & Owen, D. (2020). 18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis. European journal of nuclear medicine and molecular imaging, 47(10), 2242-2243. https://doi.org/10.1007/s00259-020-04844-5
Huo, W., Angeles, P., Tai, Y. F., Pavese, N., Wilson, S., Hu, M. T. & Vaidyanathan, R. (2020). A Heterogeneous Sensing Suite for Multisymptom Quantification of Parkinson's Disease. I E E E Transactions on Neural Systems and Rehabilitation Engineering, 28(6), 1397-1406. Article 9064818. https://doi.org/10.1109/TNSRE.2020.2978197
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A. ... Drzezga, A. (2020). Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurology, 19(11), 951-962. https://doi.org/10.1016/S1474-4422(20)30314-8
Fox, T., Siderowf, A. D., Fernandez, H. H., Tanner, C. M., Postuma, R. B., Simon, D. K., Byrne, M., Lang, A. E., Brooks, D., Rascol, O., Tolosa, E., Poewe, W., Stocchi, F., Mollenhauer, B., Giladi, N., Hirschhorn, B., Cedarbaum, J. M., Nomikos, G., Fanning, L. ... Brys, M. (2020). Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson's Disease (1579). Neurology, 94(15).
Mansur, A., Rabiner, E. A., Comley, R. A., Lewis, Y., Middleton, L. T., Huiban, M., Passchier, J., Tsukada, H., Gunn, R. N. & MIND-MAPS Consortium (2020). Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J C-SA-4503, and 11C-UCB-JC-SA-4503, and 11C-UCB-J1. Journal of Nuclear Medicine, 61(1), 96-103. https://doi.org/10.2967/jnumed.119.228080
Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T. D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D. J., Okamura, N., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder. European Journal of Neurology, 27(4), 644-652. https://doi.org/10.1111/ene.14127
Bellini, G., Best, L. A., Brechany, U., Mills, R. & Pavese, N. (2020). Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease. Movement Disorders Clinical Practice, 7(4), 373-382. https://doi.org/10.1002/mdc3.12938
Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21, Article 660. https://doi.org/10.1186/s13063-020-04608-4
Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J. ... Morris, H. R. (2020). Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology, 77(3), 377-387. https://doi.org/10.1001/jamaneurol.2019.4347
Palermo, G., Giannoni, S., Frosini, D., Morganti, R., Volterrani, D., Bonuccelli, U., Pavese, N. & Ceravolo, R. (2020). Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study. Movement Disorders, 35(6), 1028-1036. https://doi.org/10.1002/mds.28008
Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N., Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., Drzezga, A., Dubroff, J., Ekmekcioglu, O., Garibotto, V., Herscovitch, P., Kuo, P., Lammertsma, A., Pappata, S., Penuelas, I. ... Law, I. (2020). EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 47(8), 1885-1912. https://doi.org/10.1007/s00259-020-04817-8
Cai, X. L., Xie, D. J., Madsen, K. H., Wang, Y. M., Bögemann, S. A., Cheung, E. F. C., Møller, A. & Chan, R. C. K. (2020). Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data. Human Brain Mapping, 41(1), 172-184. https://doi.org/10.1002/hbm.24797
Sigurdsson, H., Yarnall, A., Galna, B., Lord, S., Alcock, L., Morris, R., Lawson, R., Colloby, S., Firbank, M., Pavese, N., Brooks, D., O'brien, J., Burn, D. & Rochester, L. (2020). Identifying neural signatures of Parkinson's disease that predict decline in gait and postural control. Movement Disorders, 35(Suppl. S1), S281-S282. https://doi.org/10.1002/mds.28268
Wang, Y. M., Yang, Z. Y., Cai, X. L., Zhou, H. Y., Zhang, R. T., Yang, H. X., Liang, Y. S., Zhu, X. Z., Madsen, K. H., Sørensen, T. A., Møller, A., Wang, Z., Cheung, E. F. C. & Chan, R. C. K. (2020). Identifying Schizo-Obsessive Comorbidity by Tract-Based Spatial Statistics and Probabilistic Tractography. Schizophrenia Bulletin, 46(2), 442-453. https://doi.org/10.1093/schbul/sbz073
Nicholas, R., Brooks, D. & Owen, D. (2020). In Response to Letter from Fregonara et al. 2019. Molecular Imaging and Biology, 22(1), 13-14. https://doi.org/10.1007/s11307-019-01463-x
Giorgi, F. S., Biagioni, F., Galgani, A., Pavese, N., Lazzeri, G. & Fornai, F. (2020). Locus coeruleus modulates neuroinflammation in parkinsonism and dementia. International Journal of Molecular Sciences , 21(22), 1-21. Article 8630. https://doi.org/10.3390/ijms21228630
Miani, A., Di Bernardo, G. A., Højgaard, A. D., Earp, B. D., Zak, P. J., Landau, A. M., Hoppe, J. & Winterdahl, M. (2020). Neonatal male circumcision is associated with altered adult socio-affective processing. Heliyon, 6(11), Article e05566. https://doi.org/10.1016/j.heliyon.2020.e05566